机构

• 上海药物研究所 [39]
• 过程工程研究所 [8]
• 自动化研究所 [6]
• 合肥物质科学研究院 [4]
• 金属研究所 [2]
• 高能物理研究所 [2]
• 更多

采集方式

• OAI收割 [64]
• iSwitch采集 [2]

内容类型

• 期刊论文 [66]

发表日期

• 2025 [1]
• 2024 [8]
• 2023 [4]
• 2022 [11]
• 2021 [14]
• 2020 [15]
• 更多

学科主题

• Engineerin... [1]
• Research &... [1]

筛选

浏览/检索结果: 共66条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择题名升序题名降序提交时间升序提交时间降序作者升序作者降序发表日期升序发表日期降序 Reversing tumor fibrosis for potentiating chemo-immunotherapy via lactic acid exhaustion by codelivery of bicarbonate and JQ1 期刊论文  OAI收割 NANO TODAY, 2025, 卷号: 61, 页码: 16 作者:  Peng, Taoxing;  He, Yihao;  Shao, Xinyue;  Liu, Han;  Yang, Lu   |  收藏  |  浏览/下载：7/0  |  提交时间：2025/04/01 sodium bicarbonate  Nano-adjuvant  Lactic acid exhaustion  Tumor fibrosis reversal  Chemo-immunotherapy   Personalized Multi-Epitope Nanovaccine Unlocks B Cell-Mediated Multiple Pathways of Antitumor Immunity 期刊论文  OAI收割 ADVANCED MATERIALS, 2024, 页码: 19 作者:  Yan, Wenlu;  Cao, Ying;  Xu, Shanshan;  Li, Yu;  Wu, Ting   |  收藏  |  浏览/下载：6/0  |  提交时间：2025/02/28 B lymphocytes  cellular immunity  humoral immunity  nanovaccine  tumor immunotherapy   Inflammatory markers correlate with lymphocytes infiltrating and predict immunotherapy prognosis for esophageal cancer 期刊论文  OAI收割 FUTURE ONCOLOGY, 2024, 页码: 12 作者:  Wang, Bei;  Wang, Zixuan;  Wang, Kun;  Shao, Zhongming;  Chen, Haitao   |  收藏  |  浏览/下载：5/0  |  提交时间：2024/12/11 esophageal squamous cell carcinoma  immunotherapy  inflammatory markers  prognosis  tumor infiltrating lymphocytes   CAR-macrophage: Breaking new ground in cellular immunotherapy 期刊论文  OAI收割 FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2024, 卷号: 12, 页码: 12 作者:  Huang, Ting;  Bei, Chenqi;  Hu, Zhenhua;  Li, Yuanyuan   |  收藏  |  浏览/下载：6/0  |  提交时间：2024/11/26 macrophage  chimeric antigen receptor  CAR-M therapy  tumor immunotherapy  solid tumor   Biomimetic Nucleic Acid Drug Delivery Systems for Relieving Tumor Immunosuppressive Microenvironment 期刊论文  OAI收割 PHARMACEUTICS, 2024, 卷号: 16, 期号: 8, 页码: 21 作者:  Yan, Wenlu;  Cao, Ying;  Yin, Qi;  Li, Yaping   |  收藏  |  浏览/下载：19/0  |  提交时间：2024/10/21 biomimetic  drug delivery system  nucleic acid  immunotherapy  tumor immunosuppressive microenvironment   Ecto-nucleotide pyrophosphatase/phosphodiesterase 1 inhibitors: Research progress and prospects 期刊论文  OAI收割 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 卷号: 267, 页码: 13 作者:  Guan, Dezhong;  Fang, Lincheng;  Feng, Mingshun;  Guo, Shi;  Xie, Lingfeng   |  收藏  |  浏览/下载：15/0  |  提交时间：2024/05/07 ENPP1 inhibitors  cGAS-STING pathway  2 ', 3 '-cGAMP  Tumor immunotherapy   Small-molecule agents for cancer immunotherapy 期刊论文  OAI收割 ACTA PHARMACEUTICA SINICA B, 2024, 卷号: 14, 期号: 3, 页码: 905-952 作者:  Wang, Fang;  Fu, Kai;  Wang, Yujue;  Pan, Can;  Wang, Xueping   |  收藏  |  浏览/下载：19/0  |  提交时间：2024/10/21 Cancer immunotherapy  Small-molecule agents  Immune checkpoints  Oncogenic signaling  Metabolic pathways  Cytokine/chemokine signaling  Antitumor immunity  Tumor immune microenvironment   Activating CD8+ T Cells by Pt(IV) Prodrug-Based Nanomedicine and aPD-L1 Antibody for Enhanced Cancer Immunotherapy 期刊论文  OAI收割 ADVANCED MATERIALS, 2024, 页码: 15 作者:  Wang, Bin;  Zhou, Jingyu;  Li, Ruitong;  Tang, Dongsheng;  Cao, Zheng   |  收藏  |  浏览/下载：28/0  |  提交时间：2024/04/09 chemotherapy  immunotherapy  immunogenic cell death  tumor immune microenvironment   The promise and challenges of combination therapies with antibody-drug conjugates in solid tumors 期刊论文  OAI收割 JOURNAL OF HEMATOLOGY & ONCOLOGY, 2024, 卷号: 17, 期号: 1, 页码: 32 作者:  Wei, Qing;  Li, Peijing;  Yang, Teng;  Zhu, Jiayu;  Sun, Lu   |  收藏  |  浏览/下载：57/0  |  提交时间：2024/02/27 Antibody-drug conjugate  Solid tumor  Combination therapy  Immunotherapy  Targeted therapy   Inhibiting Endothelial Cell-Mediated T Lymphocyte Apoptosis with Integrin-Targeting Peptide-Drug Conjugate Filaments for Chemoimmunotherapy of Triple-Negative Breast Cancer 期刊论文  OAI收割 ADVANCED MATERIALS, 2023, 页码: 12 作者:  Cai, Ying;  Zhu, Binyu;  Shan, Xiaoting;  Zhou, Lingli;  Sun, Xujie   |  收藏  |  浏览/下载：50/0  |  提交时间：2024/01/16 Fas ligand  immunotherapy  peptide-drug conjugate  triple-negative breast cancer  tumor-associated endothelial cells